Inter‐relations between growth hormone, insulin, insulin‐like growth factor‐l (IGF‐I), IGF‐binding protein‐1 (IGFBP‐1) and sex hormone‐binding globulin in acromegaly
- 1 April 1991
- journal article
- Published by Wiley in Clinical Endocrinology
- Vol. 34 (4) , 275-280
- https://doi.org/10.1111/j.1365-2265.1991.tb03766.x
Abstract
Acromegaly is characterized by a hypersecretion of GH, which in turn results in an excess of IGF-I, an important mediator of its actions. IGF-I itself is intimately related to insulin both in structure and function. IGF-I circulates associated with specific binding proteins which appear to have important effects on its activity. We have examined the inter-relations between GH, prolactin, insulin, IGF-I and one of the binding proteins, IGFBP-1, in 62 patients with acromegaly of varying activity. Serum IGF-I levels were closely related to the logarithm of mean GH levels (r = 0.76; n = 62; P less than 0.001) but multiple regression analysis suggested that, after accounting for the variation due to GH, insulin accounted for some of the additional variation of IGF-I. IGF-I concentrations were independent of prolactin. Fasting insulin levels were high and unrelated to mean GH levels but correlated with those of IGF-I (r = 0.542; n = 57; P less than 0.001). This correlation coefficient was further improved by also accounting for variations in IGFBP-1 (r = 0.684; n = 57; P less than 0.001). Even in subjects whose acromegaly was well controlled or cured, as indicated by GH levels of less than 1 mU/l or IGF-I levels of less than 2 U/ml, fasting insulin levels remained significantly elevated in some individuals. The reason for this persistent abnormality is not clear. Fasting IGFBP-1 levels were low and unrelated to mean GH but were inversely related to fasting insulin levels (r = -0.593; n = 57; P less than 0.001). We propose that a cascade of events occurs in acromegaly.(ABSTRACT TRUNCATED AT 250 WORDS)Keywords
This publication has 39 references indexed in Scilit:
- DECREASED SEX HORMONE BINDING GLOBULIN (SHBG) AND INSULIN‐LIKE GROWTH FACTOR BINDING PROTEIN (IGFBP‐1) IN EXTREME OBESITYClinical Endocrinology, 1990
- THE GROWTH HORMONE INDEPENDENT INSULIN‐LIKE GROWTH FACTOR‐I BINDING PROTEIN BP‐28 IS ASSOCIATED WITH SERUM INSULIN‐LIKE GROWTH FACTOR‐I INHIBITORY BIOACTIVITY IN ADOLESCENT INSULIN‐DEPENDENT DIABETICSClinical Endocrinology, 1990
- RELATIONSHIP BETWEEN THE PUBERTAL FALL INSEX HORMONE BINDING GLOBULIN AND INSULIN‐LIKE GROWTH FACTOR BINDING PROTEIN‐I. A SYNCHRONIZED APPROACH TO PUBERTAL DEVELOPMENT?Clinical Endocrinology, 1989
- ORCADIAN VARIATION OF GH‐INDEPENDENT IGF‐BINDING PROTEIN IN DIABETES MELLITUS AND ITS RELATIONSHIP TO INSULIN. A NEW ROLE FOR INSULIN?Clinical Endocrinology, 1988
- SOMATOMEDIN-C LEVELS IN TREATED AND UNTREATED PATIENTS WITH ACROMEGALYClinical Endocrinology, 1987
- Insulin Binding to Erythrocyte Receptors in Acromegalic Patients in Relation to the Activity of Acromegaly and to Concomitant Diabetes MellitusExperimental and Clinical Endocrinology & Diabetes, 1986
- GLUCOSE TOLERANCE AND PLASMA IMMUNOREACTIVE INSULIN LEVELS IN ACROMEGALICS BEFORE AND AFTER SELECTIVE TRANSSPHENOIDAL SURGERYClinical Endocrinology, 1985
- Estradiol treatment of acromegaly Reduction of immunoreactive somatomedin-C and improvement in metabolic statusThe American Journal of Medicine, 1980
- AN ASSESSMENT OF GLUCOSE INTOLERANCE IN ACROMEGALY AND ITS RESPONSE TO MEDICAL TREATMENTClinical Endocrinology, 1980
- Long-term treatment of acromegaly with bromocriptine.BMJ, 1977